Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade After Approval
Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB) [...]
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2025-07-01
|
| Серии: | Toxins |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/2072-6651/17/7/351 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|